Search

everythinglearnresearchcommunity

for

Search:↓

Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.

TRPV channels are important in osteoarthritis and could be key to new treatments.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

EDA is vital for bone and cartilage formation and could help treat skeletal disorders.

Antiandrogens don't help with COVID-19 and aren't recommended.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Long COVID is a big health problem needing more research and better treatments.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Exploring fermented foods from various regions can lead to discovering new fibrinolytic enzymes.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Microbial-derived polydeoxyribonucleotide is a better and more sustainable alternative to salmon-based versions for healing and immune support.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Future hair cosmetics will be safer and more effective.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

People with autism are more likely to develop alopecia areata than those without autism.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.